WallStreetZenWallStreetZen

NASDAQ: RZLT
Rezolute Inc Stock Forecast, Predictions & Price Target

Analyst price target for RZLT

Based on 4 analysts offering 12 month price targets for Rezolute Inc.
Min Forecast
$7.00+144.76%
Avg Forecast
$9.75+240.91%
Max Forecast
$14.00+389.51%

Should I buy or sell RZLT stock?

Based on 4 analysts offering ratings for Rezolute Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RZLT stock forecasts and price targets.

RZLT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-19
lockedlocked$00.00+00.00%2024-04-18
lockedlocked$00.00+00.00%2024-04-09
lockedlocked$00.00+00.00%2024-03-07

1 of 1

Forecast return on equity

Is RZLT forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.5%

Forecast return on assets

Is RZLT forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

RZLT revenue forecast

What is RZLT's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$4.3M
Avg 2 year Forecast
$75.3M
Avg 3 year Forecast
$306.8M

RZLT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RZLT$2.86$9.75+240.91%Strong Buy
CTMX$1.68$3.13+86.01%Hold
MCRB$0.76$4.75+525.00%Hold
IMUX$1.24$10.00+706.45%Strong Buy
RNAC$20.59$47.00+128.27%Buy

Rezolute Stock Forecast FAQ

Is Rezolute Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: RZLT) stock is to Strong Buy RZLT stock.

Out of 4 analysts, 2 (50%) are recommending RZLT as a Strong Buy, 2 (50%) are recommending RZLT as a Buy, 0 (0%) are recommending RZLT as a Hold, 0 (0%) are recommending RZLT as a Sell, and 0 (0%) are recommending RZLT as a Strong Sell.

If you're new to stock investing, here's how to buy Rezolute stock.

What is RZLT's revenue growth forecast for 2026-2028?

(NASDAQ: RZLT) Rezolute's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Rezolute's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast RZLT's revenue for 2026 to be $168,803,654, with the lowest RZLT revenue forecast at $168,803,654, and the highest RZLT revenue forecast at $168,803,654. On average, 1 Wall Street analysts forecast RZLT's revenue for 2027 to be $2,981,801,643, with the lowest RZLT revenue forecast at $2,981,801,643, and the highest RZLT revenue forecast at $2,981,801,643.

In 2028, RZLT is forecast to generate $12,155,448,132 in revenue, with the lowest revenue forecast at $12,155,448,132 and the highest revenue forecast at $12,155,448,132.

What is RZLT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: RZLT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is RZLT's Price Target?

According to 4 Wall Street analysts that have issued a 1 year RZLT price target, the average RZLT price target is $9.75, with the highest RZLT stock price forecast at $14.00 and the lowest RZLT stock price forecast at $7.00.

On average, Wall Street analysts predict that Rezolute's share price could reach $9.75 by Apr 19, 2025. The average Rezolute stock price prediction forecasts a potential upside of 240.91% from the current RZLT share price of $2.86.

What is RZLT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: RZLT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.